Finn
CHE Healthcare Services · Hospice · Home services · Thesis updated August 11, 2026

VITAS accelerates while Roto-Rooter battles search marketing costs

01 Running thesis

Hospice strength meets search-cost pain

Chemed's story improved significantly through the first half of 2026. VITAS, the hospice business, beat expectations in the second quarter and management raised full-year guidance. The Florida Medicare Cap issue from 2025 is fully resolved, with zero penalty accrued in Q2 2026. The Medicare Cap is a limit on how much Medicare will pay a hospice provider for a group of patients over a year.

The bull case is simple. VITAS keeps adding care capacity, grows patient days, and overcomes past regulatory hurdles. In Q2 2026, VITAS net revenue reached $443.3 million, up 11.9%, driven by a 6.1% increase in days of care. Management even updated full-year average daily census growth to a higher range of 5.75% to 6.25%.

The bear case sits entirely inside Roto-Rooter. The plumbing brand showed top-line stability, but the way customers find Roto-Rooter has permanently changed. Free leads from Google search fell 13.1% in Q2 2026, and paid advertisements now make up approximately 59% of total leads. This structural shift is compressing profit margins as internet marketing costs rise.

The next test is execution in the second half of 2026. Investors should watch whether Roto-Rooter can maintain core plumbing growth and improve its water restoration collections through centralized billing. If those efforts fail, VITAS will have to carry the entire company's growth story.

Jul 2026The Q2 2026 Form 10-Q confirmed a strong quarter for VITAS, offsetting ongoing structural margin pressure and paid lead reliance at Roto-Rooter.
Jul 2026VITAS significantly outperformed expectations in Q2 2026, prompting increased full-year guidance, while Roto-Rooter saw paid leads hit 59% of its total mix.
Apr 2026The Q1 2026 Form 10-Q confirmed the earnings update. VITAS grew, Roto-Rooter slipped slightly, and the filing did not add a new material risk.
Apr 2026Q1 2026 improved the thesis because VITAS beat expectations and full-year guidance moved higher. Roto-Rooter also showed its first core residential service growth since Q4 2022.
Feb 2026The 2025 Form 10-K confirmed the Roto-Rooter lead-generation risk and noted that AI use by customers can make marketing harder.
Feb 2026Q4 2025 missed expectations at both subsidiaries. VITAS was hurt by the Florida Medicare Cap response, and Roto-Rooter was hit by water restoration write-offs.
Oct 2025The Q3 2025 Form 10-Q backed the existing view. VITAS kept growing, while Roto-Rooter stayed sluggish as drain cleaning weakness offset gains in other services.
Oct 2025Q3 2025 showed better Roto-Rooter margin direction and clearer confidence that the 2025 Florida Medicare Cap problem would not repeat in 2026.
02 Business model

Two service businesses, two rulebooks

Chemed makes money through two wholly owned subsidiaries. VITAS provides hospice and palliative care, mostly paid through Medicare. Roto-Rooter provides plumbing, drain cleaning, excavation, water restoration, and related services to homes and businesses.

VITAS grows when it serves more patient days, hires enough clinical staff, earns Medicare rate increases, and expands into new regions via Certificates of Need. The historical weak spot is regulation, because Medicare rules and billing limits can change economics quickly, though recent quarters show VITAS navigating this successfully.

Roto-Rooter has a more consumer-driven model. Management typically targets 5% to 6% long-term top-line growth, helped by annual price increases and housing demand. The problem is that demand now costs more to capture. Search engine changes and customer use of AI platforms are forcing a permanent, expensive reliance on paid search channels.

Chemed balances these diverse cash flows to fund operations, acquisitions, and shareholder returns through buybacks and dividends.

03 Product portfolio

Care beds and clogged drains

Steady

VITAS routine homecare

This is the core hospice service, delivered where patients live. It provides the reliable base of VITAS revenue.

Option

VITAS inpatient and continuous care

These are higher-acuity hospice services for patients who need more intense care. Mix can move overall segment results.

Growth engine

Hospice expansion through CONs

Certificates of Need are state approvals that limit new competitors and open growth paths. Execution on newly awarded CONs is part of the bull case.

Cash cow

Roto-Rooter plumbing

Plumbing is a core Roto-Rooter service for homes and businesses. Q2 2026 branch residential revenue rose 1.7%.

Steady

Roto-Rooter drain cleaning

Drain cleaning is a high-recognition service tied to urgent, everyday customer needs.

Option

Roto-Rooter water restoration

Water restoration can be attractive when jobs bill cleanly, but it is under pressure. Q2 2026 water restoration revenue fell 6.7%.

04 Business segments

VITAS carries the mix

VITAS Healthcare65%modest
Roto-Rooter35%flat

Segment shares are approximate based on recent historical contribution, with VITAS generating roughly two-thirds of total service revenues.

05 Risk factors

What could break the story

Paid-search margin trap

High impact · High odds

Roto-Rooter depends more on paid leads because free search leads fell 13.1% after Google algorithm changes. Paid advertisements made up 59% of total leads in Q2 2026. This forces permanent, expensive reliance on paid channels, compressing EBITDA margin.

We watchPaid leads as a share of total leads, free search lead growth, and Roto-Rooter EBITDA margin.

Water restoration billing pushback

Medium impact · Medium odds

Insurance companies are using AI to review water restoration bills line by line, increasing scrutiny on claims. This segment saw a 6.7% revenue decline in Q2 2026. Centralized billing is meant to improve collections, but the fix still needs proof.

We watchWater restoration revenue growth, write-offs, credit memos, and management comments on centralized billing.

Hospice reimbursement and audit risk

High impact · Medium odds

VITAS depends heavily on Medicare, making the Medicare regulator CMS critical. While the Florida Medicare Cap issue is solved for 2026, hospice remains a politically sensitive area where rule changes or audits can alter profitability.

We watchMedicare cap accruals, CMS rule changes, audit activity, and VITAS margin.

Consumer and cost pressure

Medium impact · Medium odds

Roto-Rooter can be hurt when consumers delay non-emergency work. Inflation, tariffs, and macro pressures may also hurt future sales and profitability. The company expects some resilience, but consumer spending shifts remain a risk.

We watchNon-emergency service demand, fuel costs, tariff commentary, and Roto-Rooter gross margin.
06 Quick answers

In one breath

What does Chemed Corporation do?

Chemed owns two main businesses. VITAS Healthcare provides hospice and palliative care, while Roto-Rooter provides plumbing, drain cleaning, excavation, and water restoration services.

Is Chemed more healthcare or plumbing?

Chemed is mostly a healthcare company. VITAS makes up roughly 65% of overall service revenues and sales, with Roto-Rooter providing the rest.

Why is Roto-Rooter a problem for Chemed?

Roto-Rooter is facing higher marketing costs because free search leads are down and paid ads are a larger share of leads. Water restoration billing is also under pressure as insurers review claims more closely.

What is the key thing to watch next for Chemed?

Watch whether VITAS can maintain its strong growth trajectory. Also watch whether Roto-Rooter can stabilize its margins despite higher paid marketing costs.

Get started with Finn today